Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02778659Completed
Randomised, double-blind trial of zolpidem sublingual tablet in Insomnia (4 arms), sponsored by EXALT. Primary endpoint: Simon cognitive test. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02778659.